This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.This is a randomized, non-blinded, comparative study that will evaluate the effects of Exenatide on endothelial function and arterial stiffness. 60 subjects with poorly controlled diabetes on either Metformin, a Sulfonylurea, or both, with type 2 diabetes will be randomized to treatment with either Exenatide of Lantus insulin. They will have a baseline evaluation prior to starting treatment, which will include: flow mediated dilation, to evaluate the endothelial-dependent vasodilation, pulse wave analysis to assess arterial stiffness, and response to nitroglycerin to evaluate endothelial-independent vasodilation. These tests will be performed both before and after a meal tolerance test, along with laboratory markers: endothelial function, inflammation and oxidative stress, at various time points over the course of three hours. Subjects will then be randomized to treatment with Exenatide or Lantus. Exenatide dose will be increased after 4 weeks, and Lantus dose will be titrated every other week to achieve the target fasting blood glucose. After 12 weeks, subjects will return for repeat baseline studies, as well as a meal tolerance test, with repeat studies and laboratory evaluation afterwards. The primary endpoints will be endothelial-dependent vasodilation, endothelial-independent vasodilation and arterial stiffness. Secondary endpoints will include the markers of inflammation, endothelial function and oxidative stress.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR001032-33
Application #
7718971
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2008-04-01
Project End
2008-05-31
Budget Start
2008-04-01
Budget End
2008-05-31
Support Year
33
Fiscal Year
2008
Total Cost
$8,372
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
Nowak, Kristen L; You, Zhiying; Gitomer, Berenice et al. (2018) Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol 29:571-578
Chung, Chen-Chih; Pimentel Maldonado, Daniela A; Jor'dan, Azizah J et al. (2018) Lower cerebral vasoreactivity as a predictor of gait speed decline in type 2 diabetes mellitus. J Neurol 265:2267-2276
Kline, Emily R; Seidman, Larry J; Cornblatt, Barbara A et al. (2018) Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort. Schizophr Res 192:357-363
Simpson, Norah S; Scott-Sutherland, Jennifer; Gautam, Shiva et al. (2018) Chronic exposure to insufficient sleep alters processes of pain habituation and sensitization. Pain 159:33-40
Dai, Weiying; Duan, Wenna; Alfaro, Freddy J et al. (2017) The resting perfusion pattern associates with functional decline in type 2 diabetes. Neurobiol Aging 60:192-202
Brosnahan, Godela M; Abebe, Kaleab Z; Rahbari-Oskoui, Frederic F et al. (2017) Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev 13:109-120
Torres, Vicente E; Abebe, Kaleab Z; Schrier, Robert W et al. (2017) Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Kidney Int 91:493-500
Irazabal, María V; Abebe, Kaleab Z; Bae, Kyongtae Ty et al. (2017) Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. Nephrol Dial Transplant 32:1857-1865
Hart, Joseph; Novak, Vera; Saunders, Charles et al. (2016) Transcranial Doppler-Based Surrogates for Cerebral Blood Flow: A Statistical Study. PLoS One 11:e0165536
Alfaro, Freddy J; Lioutas, Vasileios-Arsenios; Pimentel, Daniela A et al. (2016) Cognitive decline in metabolic syndrome is linked to microstructural white matter abnormalities. J Neurol 263:2505-2514

Showing the most recent 10 out of 642 publications